Literature DB >> 23071858

Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases.

Teng Hou1, Dongxia Liang, Jiehua He, Xu Chen, Yanna Zhang.   

Abstract

AIMS: Primary peritoneal serous carcinoma (PPSC) is an unusual neoplasm that has not been properly characterized. To better define the clinicopathological and immunohistochemical features of PPSC, we present 6 such cases.
METHODS: The 6 patients consisted of one man and 5 women, ranging in age from 45 and 75 years. None of the patients had any history or clinical evidence of tumor elsewhere. The immunohistochemical profile was examined using antibodies against β-catenin, E-cadherin, wnt5a, EGFR, VEGF, vimentin, Ki67, and P53.
RESULTS: Of all the 6 PPSC cases, 5 cases presented stage IIIC and 1 case presented stage IV. Microscopically, 5 cases were poorly differentiated and 1 was moderately differentiated. All cases showed positive staining for β-catenin, E-cadherin, vimentin, VEGF, P53, and Ki67, 4 cases expressed EGFR, and all cases were consistently negative for wnt5a.
CONCLUSIONS: We described 6 cases of PPSC with clinicopathological and immunohistochemical features. The findings provide basic knowledge of PPSC.

Entities:  

Keywords:  Primary peritoneal serous carcinoma; epithelial ovarian cancer; serous carcinoma

Mesh:

Substances:

Year:  2012        PMID: 23071858      PMCID: PMC3466985     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

1.  Epithelial-mesenchymal interactions in breast cancer: evidence for a role of nuclear localized β-catenin in carcinoma-associated fibroblasts.

Authors:  Eldo T Verghese; Hrishikesh Shenoy; Victoria J Cookson; Caroline A Green; Jo Howarth; R H Partanen; Steven Pollock; Alison Waterworth; Valerie Speirs; Thomas A Hughes; Andrew M Hanby
Journal:  Histopathology       Date:  2011-10       Impact factor: 5.087

2.  The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression.

Authors:  Livia Quattrocchi; Andrew R Green; Stewart Martin; Lindy Durrant; Suha Deen
Journal:  Virchows Arch       Date:  2011-04-21       Impact factor: 4.064

3.  Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases.

Authors:  L D Truong; M L Maccato; H Awalt; P T Cagle; M R Schwartz; A L Kaplan
Journal:  Hum Pathol       Date:  1990-01       Impact factor: 3.466

4.  BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis.

Authors:  J O Schorge; M G Muto; S J Lee; L W Huang; W R Welch; D A Bell; E Z Keung; R S Berkowitz; S C Mok
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

5.  Endobronchial metastasis from primary papillary serous carcinoma of the peritoneum.

Authors:  Makoto Nakao; Tetsuya Oguri; Ken Maeno; Chiharu Ota; Osamu Takakuwa; Yasuhito Iwashima; Mikinori Miyazaki; Takeo Kutsuna; Atsushi Nakamura; Shigeki Sato; Ryuzo Ueda
Journal:  Intern Med       Date:  2009-07-01       Impact factor: 1.271

Review 6.  Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: a review.

Authors:  Shozo Yoshida; Naoto Furukawa; Shoji Haruta; Yasuhito Tanase; Seiji Kanayama; Taketoshi Noguchi; Mariko Sakata; Yoshihiko Yamada; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Int J Gynecol Cancer       Date:  2009-08       Impact factor: 3.437

7.  Scoring of p16(INK4a) immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study.

Authors:  Chih-Ping Han; Lai-Fong Kok; Po-Hui Wang; Tina S Wu; Yeu-Sheng Tyan; Ya-Wen Cheng; Ming-Yung Lee; Shun-Fa Yang
Journal:  Mod Pathol       Date:  2009-04-03       Impact factor: 7.842

8.  An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.

Authors:  Aurelia Noske; Michael Schwabe; Wilko Weichert; Silvia Darb-Esfahani; Ann-Christin Buckendahl; Jalid Sehouli; Elena I Braicu; Jan Budczies; Manfred Dietel; Carsten Denkert
Journal:  BMC Cancer       Date:  2011-07-14       Impact factor: 4.430

9.  Immunohistochemical identification of primary peritoneal serous cystadenocarcinoma mimicking advanced colorectal carcinoma: a case report.

Authors:  Wesley B von Riedenauer; Sumbul A Janjua; David S Kwon; Ziying Zhang; Vic Velanovich
Journal:  J Med Case Rep       Date:  2007-11-26

10.  Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation.

Authors:  Xiaoyun Liao; Michelle K Y Siu; Christy W H Au; Esther S Y Wong; Hoi Yan Chan; Philip P C Ip; Hextan Y S Ngan; Annie N Y Cheung
Journal:  Carcinogenesis       Date:  2008-11-20       Impact factor: 4.944

View more
  5 in total

1.  Primary peritoneal serous carcinoma: a rare case and palliative approach.

Authors:  Viral M Bhanvadia; Jignesh K Parmar; Yogendra G Madan; Shamim S Sheikh
Journal:  Indian J Palliat Care       Date:  2014-05

2.  Primary peritoneal serous carcinoma, an extremely rare malignancy: A case report and review of the literature.

Authors:  Woo-Sung Yun; Jung-Min Bae
Journal:  Oncol Lett       Date:  2016-05-05       Impact factor: 2.967

3.  Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.

Authors:  Lauren Patterson Cobb; Stephanie Gaillard; Yihong Wang; Ie-Ming Shih; Angeles Alvarez Secord
Journal:  Gynecol Oncol Res Pract       Date:  2015-05-12

4.  Immunohistochemical Characterization of Normal Ovary and Common Epithelial Ovarian Neoplasm with a Monoclonal Antibody to Cytokeratin and Vimentin.

Authors:  Ankita Goel; Nandam Mohan Rao; Vissa Santhi; Syam Sundar Byna; Bhavana Grandhi; Jyothi Conjeevaram
Journal:  Iran J Pathol       Date:  2018

5.  Cutaneous metastasis of unknown primary presenting as massive and invasive abdominal lesion: an elective approach with electrochemotherapy.

Authors:  Paolo Lido; Giovanni Paolino; Andrea Feliziani; Letizia Santurro; Mauro Montuori; Flavio de Sanctis; Piero Rossi; Giuseppe Petrella; Edoardo Ricciardi; Giuseppe Fusano; Orlandi Augusto; Patrizio Polisca
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.